These results indicated that Ad-CAIX/Ad-PD-L1 could significantly increase the induction and maturation of DCs in vivo, and promote the uptake and presentation of tumor antigens, and thus activate the antigen-specific CD8+ T cell immune responses. The gene discussed is CA9; the disease is neoplasm.